Trelagliptin
Sponsors
Takeda, British University In Egypt
Conditions
Diabetes MellitusType 2 DiabetesType 2 Diabetes Mellitus
Phase 4
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
CompletedNCT02771093
Start: 2016-09-08End: 2017-04-27Updated: 2023-12-12
Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus
CompletedNCT03014479
Start: 2017-02-18End: 2017-10-21Updated: 2023-12-22
Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus
CompletedNCT03231709
Start: 2017-08-18End: 2018-02-09Updated: 2023-12-22
Dose Modification Requirement for Trelagliptin in Egyptian Population
NCT04374864
Start: 2020-03-01End: 2020-07-01Target: 6Updated: 2020-05-05
Unknown Phase
Specified Drug-Use Survey of Trelagliptin Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
CompletedNCT03555591
Start: 2016-05-01End: 2021-10-31Updated: 2023-12-12
Specified Drug-Use Survey of Trelagliptin Tablets Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease
CompletedNCT04285983
Start: 2020-03-01End: 2023-01-31Updated: 2024-08-23